Anavex Life Sciences (AVXL) Receives 600K Grant to Commence Phase 2 Trial in 2017
Tweet Send to a Friend
Anavex Life Sciences Corp. (Nasdaq: AVXL) and the International Rett Syndrome Foundation, doing business as Rettsyndrome.org today announced that Rettsyndrome.org ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE